vs

Side-by-side financial comparison of Cenntro Inc. (CENN) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Cenntro Inc. is the larger business by last-quarter revenue ($5.0M vs $3.8M, roughly 1.3× Vivos Therapeutics, Inc.). Vivos Therapeutics, Inc. runs the higher net margin — -180.3% vs -1022.8%, a 842.6% gap on every dollar of revenue. On growth, Cenntro Inc. posted the faster year-over-year revenue change (972.9% vs 3.4%). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -17.7%).

Cenntro Inc. is a global electric vehicle technology manufacturer specializing in light and medium-duty commercial electric vehicles and associated smart mobility solutions. It serves logistics, urban delivery, public service, and corporate fleet markets across North America, Europe, and Asia, focusing on affordable, sustainable last-mile transport options.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

CENN vs VVOS — Head-to-Head

Bigger by revenue
CENN
CENN
1.3× larger
CENN
$5.0M
$3.8M
VVOS
Growing faster (revenue YoY)
CENN
CENN
+969.5% gap
CENN
972.9%
3.4%
VVOS
Higher net margin
VVOS
VVOS
842.6% more per $
VVOS
-180.3%
-1022.8%
CENN
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-17.7%
CENN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CENN
CENN
VVOS
VVOS
Revenue
$5.0M
$3.8M
Net Profit
$-50.7M
$-6.9M
Gross Margin
-54.9%
78.1%
Operating Margin
-229.9%
-166.8%
Net Margin
-1022.8%
-180.3%
Revenue YoY
972.9%
3.4%
Net Profit YoY
-189.4%
-143.8%
EPS (diluted)
$-86.61
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CENN
CENN
VVOS
VVOS
Q4 25
$5.0M
$3.8M
Q3 25
$4.6M
$6.8M
Q2 25
$2.1M
$3.8M
Q1 25
$6.4M
$3.0M
Q4 24
$-568.2K
$3.7M
Q3 24
$16.2M
$3.9M
Q2 24
$8.3M
$4.1M
Q1 24
$7.3M
$3.4M
Net Profit
CENN
CENN
VVOS
VVOS
Q4 25
$-50.7M
$-6.9M
Q3 25
$-6.7M
$-5.4M
Q2 25
$-5.7M
$-5.0M
Q1 25
$-9.9M
$-3.9M
Q4 24
$-17.5M
$-2.8M
Q3 24
$-9.0M
$-2.6M
Q2 24
$-9.2M
$-1.9M
Q1 24
$-9.2M
$-3.8M
Gross Margin
CENN
CENN
VVOS
VVOS
Q4 25
-54.9%
78.1%
Q3 25
2.3%
58.0%
Q2 25
15.0%
55.2%
Q1 25
-0.3%
50.0%
Q4 24
262.5%
56.7%
Q3 24
38.8%
60.5%
Q2 24
14.7%
65.4%
Q1 24
21.6%
56.7%
Operating Margin
CENN
CENN
VVOS
VVOS
Q4 25
-229.9%
-166.8%
Q3 25
-150.4%
-69.8%
Q2 25
-288.1%
-127.4%
Q1 25
-126.4%
-129.9%
Q4 24
1644.3%
-75.9%
Q3 24
-40.4%
-68.5%
Q2 24
-106.0%
-47.8%
Q1 24
-97.3%
-110.7%
Net Margin
CENN
CENN
VVOS
VVOS
Q4 25
-1022.8%
-180.3%
Q3 25
-146.7%
-79.6%
Q2 25
-263.8%
-131.2%
Q1 25
-154.4%
-128.1%
Q4 24
3084.9%
-76.4%
Q3 24
-55.3%
-67.8%
Q2 24
-110.4%
-47.6%
Q1 24
-125.5%
-110.1%
EPS (diluted)
CENN
CENN
VVOS
VVOS
Q4 25
$-86.61
$-0.58
Q3 25
$-0.14
$-0.49
Q2 25
$-0.19
$-0.55
Q1 25
$-0.27
$-0.45
Q4 24
$-86.39
$0.41
Q3 24
$-0.29
$-0.40
Q2 24
$-0.30
$-0.60
Q1 24
$-0.30
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CENN
CENN
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$4.5M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$40.3M
$-1.5M
Total Assets
$74.4M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CENN
CENN
VVOS
VVOS
Q4 25
$4.5M
$2.0M
Q3 25
$4.4M
$3.1M
Q2 25
$6.0M
$4.4M
Q1 25
$8.5M
$2.3M
Q4 24
$12.6M
$6.3M
Q3 24
$22.4M
$6.3M
Q2 24
$20.2M
$6.9M
Q1 24
$24.3M
$2.6M
Total Debt
CENN
CENN
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
CENN
CENN
VVOS
VVOS
Q4 25
$40.3M
$-1.5M
Q3 25
$76.0M
$2.5M
Q2 25
$79.6M
$4.6M
Q1 25
$73.3M
$4.4M
Q4 24
$77.8M
$8.0M
Q3 24
$96.7M
$7.7M
Q2 24
$103.8M
$6.3M
Q1 24
$112.5M
$582.0K
Total Assets
CENN
CENN
VVOS
VVOS
Q4 25
$74.4M
$25.2M
Q3 25
$112.7M
$25.6M
Q2 25
$124.4M
$26.0M
Q1 25
$129.3M
$11.3M
Q4 24
$132.6M
$15.3M
Q3 24
$159.8M
$15.3M
Q2 24
$167.8M
$15.8M
Q1 24
$173.0M
$11.8M
Debt / Equity
CENN
CENN
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CENN
CENN
VVOS
VVOS
Operating Cash FlowLast quarter
$-1.8M
$-3.8M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-139.7%
Capex IntensityCapex / Revenue
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CENN
CENN
VVOS
VVOS
Q4 25
$-1.8M
$-3.8M
Q3 25
$-1.4M
$-4.2M
Q2 25
$-4.4M
$-3.5M
Q1 25
$-5.0M
$-3.8M
Q4 24
$-8.5M
$-2.9M
Q3 24
$-201.6K
$-4.2M
Q2 24
$-3.8M
$-3.0M
Q1 24
$-8.9M
$-2.5M
Free Cash Flow
CENN
CENN
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-1.5M
$-4.2M
Q2 25
$-4.5M
$-4.3M
Q1 25
$-5.5M
$-3.9M
Q4 24
$-8.6M
$-3.1M
Q3 24
$-258.9K
$-4.4M
Q2 24
$-4.2M
$-3.1M
Q1 24
$-9.2M
$-2.7M
FCF Margin
CENN
CENN
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-33.2%
-62.6%
Q2 25
-211.2%
-111.6%
Q1 25
-85.4%
-129.9%
Q4 24
1509.3%
-84.0%
Q3 24
-1.6%
-113.4%
Q2 24
-50.3%
-76.7%
Q1 24
-125.7%
-78.0%
Capex Intensity
CENN
CENN
VVOS
VVOS
Q4 25
40.0%
Q3 25
2.1%
1.2%
Q2 25
5.6%
20.2%
Q1 25
8.1%
4.0%
Q4 24
-22.1%
4.5%
Q3 24
0.4%
5.0%
Q2 24
4.0%
1.5%
Q1 24
4.5%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CENN
CENN

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons